Led a ~$7M financing round (Series B) for PanTher Therapeutics, a localized pancreatic cancer treatment company.
PanTher Therapeutics is redefining cancer treatment with a technology that enables continuous, high-dose administration of cancer-fighting drugs directly at the tumor site, minimizing side effects and enhancing therapeutic effects
PanTher Therapeutics is redefining cancer treatment with a technology that enables continuous, high-dose administration of cancer-fighting drugs directly at the tumor site, minimizing side effects and enhancing therapeutic effects.